- Fee assured
- Awaiting verification
- Upper GI surgery
Richard specialises in laparoscopic (keyhole) surgery. His specialist interests include the treatment of gallstones, hernias, reflux and obesity.
He graduated from Manchester University in 1998. He completed his surgical training in the North West and South West of the UK. He became a fellow of the Royal College of Surgeons in 1992.
After research in Louisville, USA, he was awarded an MD by Manchester University.
After a fellowship in advanced laparoscopic surgery in South Australia, he was appointed Consultant Specialist UGI Surgeon at the Royal United Hospital and Bristol Royal Infirmary in 2001.
Mr Krysztopik has continued to develop considerable experience in minimally invasive (keyhole) surgery. He is an expert for complex gallbladder disease, reflux surgery and keyhole hernia surgery. He is the local NHS lead for patients with oesophageal and gastric cancer, helping co-ordinate a large multidisciplinary team.
Richard in an active researcher and educator, leading regional educational programmes. He is the South West representative for the Association of UGI Surgeons. He leads the Somerset, Wiltshire, Avon and Gloucestershire UGI Cancer Network.
Richard was born in Lancashire and brought up in the North West of England. He has lived in Bath for nearly 20 years. He is married with three children. When not being told what to do by his teenage children, he enjoys cycling, the arts and cooking for friends.
Areas of interest
Laparoscopic cholecystectomy; Reflux Surgery; Hernia Surgery; Bariatric surgery (for obesity); Gastro-oesophageal reflux; Upper gastro-intestinal disease; Gastro-intestinal tract (surgery); Minimal access / invasive surgery; Laparoscopic procedures ('keyhole surgery')
- Helen Darvill
- 01225 838853
Anaesthetists worked with
- Dr Paul E Hersch Not Fee Assured
- Bath Anaesthetic Group LLP Not Fee Assured
- Dr Andrew Paul Georgiou Fee Assured
Current NHS consultant posts held
Consultant UGI Surgeon
Royal United Hospital, Bath
pH studies and manometry
Advanced laparoscopic surgery
1983 – 1988: Victoria University of Manchester, MB ChB 1988, Honours in Surgery, Honours in Biochemistry, Douglas Award in Anatomy
1992: FRCS (England)
1993: Advanced Trauma Life Support Provider
1998: Arris and Gale Lecturer, Royal College of Surgeons of England
2000: MD, University of Manchester
2000: Intercollegiate Examination in General Surgery
(Additional) Languages spoken
- Polish - Fluent
1: Griffiths EA, Hodson J, Vohra RS, Marriott P, Katbeh T, Zino S, Nassar AHM;
CholeS Study Group, West Midlands Research Collaborative. Correction to:
Utilisation of an operative difficulty grading scale for laparoscopic
cholecystectomy. Surg Endosc. 2018 Aug 22.
2: STARSurg Collaborative. Association between peri-operative
angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and
acute kidney injury in major elective non-cardiac surgery: a multicentre,
prospective cohort study. Anaesthesia. 2018 Oct;73(10):1214-1222. doi:
10.1111/anae.14349. Epub 2018 Jul 9.
3: Jepson M, Elliott D, Conefrey C, Wade J, Rooshenas L, Wilson C, Beard D,
Blazeby JM, Birtle A, Halliday A, Stein R, Donovan JL; CSAW study group; Chemorad
study group; POUT study group; ACST-2 study group; OPTIMA prelim study group. An
observational study showed that explaining randomization using gambling-related
metaphors and computer-agency descriptions impeded randomized clinical trial
recruitment. J Clin Epidemiol. 2018 Jul;99:75-83.
4: Bharamgoudar R, Sonsale A, Hodson J, Griffiths E; CholeS Study Group, West
Midlands Research Collaborative. The development and validation of a scoring tool
to predict the operative duration of elective laparoscopic cholecystectomy. Surg
Endosc. 2018 Jul;32(7):3149-3157.
5: Alderson D, Cunningham D, Nankivell M, Blazeby JM, Griffin SM, Crellin A,
Grabsch HI, Langer R, Pritchard S, Okines A, Krysztopik R, Coxon F, Thompson J,
Falk S, Robb C, Stenning S, Langley RE. Neoadjuvant cisplatin and fluorouracil
versus epirubicin, cisplatin, and capecitabine followed by resection in patients
with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3
trial. Lancet Oncol. 2017 Sep;18(9):1249-1260.
6: CholeS Study Group, West Midlands Research Collaborative. Population-based
cohort study of variation in the use of emergency cholecystectomy for benign
gallbladder diseases. Br J Surg. 2016 Nov;103(12):1716-1726.
7: CholeS Study Group, West Midlands Research Collaborative. Population-based
cohort study of outcomes following cholecystectomy for benign gallbladder
diseases. Br J Surg. 2016 Nov;103(12):1704-1715.
8: Sutton AJ, Vohra RS, Hollyman M, Marriott PJ, Buja A, Alderson D, Pasquali S,
Griffiths EA; CholeS Study Group and the West Midlands Research Collaborative.
Cost-effectiveness of emergency versus delayed laparoscopic cholecystectomy for
acute gallbladder pathology. Br J Surg. 2017 Jan;104(1):98-107.
Reference number 3290899
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.